Annual report pursuant to Section 13 and 15(d)

STOCKBASED COMPENSATION (Tables)

v3.23.1
STOCKBASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award The following table contains information about both plans as of December 31, 2022:
Awards
Reserved
for Issuance
Awards
Exercised
Awards
Outstanding
Awards
Available
for Grant
2016 Equity Incentive Plan 999,906  —  499,953  499,953 
2018 Equity Incentive Plan 29,920,933  4,022,133  13,326,509  12,572,291 
2019 Equity Incentive Plan 61,109,696  34,884  37,617,531  23,457,281 

Stock-Based Compensation Expense
The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:
(in thousands, except for number of shares or options)
For the Year Ended
December 31, 2022 December 31, 2021
Type of Award Number of
Shares or
Options
Granted
Stock-Based Compensation
 Expense
Number of
Shares or
Options
Granted
Stock-
Based
Compensation
Expense
Stock Options 1,075,001  $ 3,659  89,930,019  $ 2,415 
Stock Grants:
Employees (Common Stock) 2,100,000  352  250,000  68 
Directors (Common Stock) 943,128  213  1,917,837  495 
Non–Employee Consultants (Common Stock) 16,906,230  695  4,556,603  1,079 
Total Stock–Based Compensation Expense $ 4,919  $ 4,057 
The service period is generally the vesting period. The following weighted-average assumptions were used to calculate stock-based compensation:
Year Ended December 31,
2022 2021
Expected Term 5.2 years 5 years
Volatility 103.0  % 106.7  %
Risk-Free Interest Rate 0.9  % 0.8  %
Dividend Yield % %
Share-based Payment Arrangement, Option, Activity
The following table summarizes the Company’s stock option activity and related information for the years ended December 31, 2022 and 2021:
Number
of Shares
Weighted-
Average
Exercise
Price
Per Share
Weighted-
Average
Remaining Contractual
Life
Aggregate
Intrinsic
Value of In-
the-Money
Options
Options Outstanding as of December 31, 2020 17,492,830  $ 0.41 
Granted 88,627,220  $ 0.23 
Exercised (3,910,805) $ — 
Forfeited (13,547,745) $ 0.15 
Expired (410,120) $ 0.41 
Options Outstanding as of December 31, 2021 88,251,380  $ 0.20 
Granted 1,075,001  $ 0.14 
Exercised (146,212) $ 0.07 
Forfeited (19,365,073) $ 0.13 
Expired (16,993,997) $ 0.17 
Options Outstanding as of December 31, 2022 52,821,099  $ 0.23  7.9 years $ 2,846 
Options Exercisable as of December 31, 2022 36,825,119  $ 0.27   7.6 years $